Amanda Psyrri

9PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurosciences not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 03, 2025
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.

Jean Bourhis, Lisa F Licitra, Barbara Burtness

|Jun 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.

Jean-Pascal Machiels, Jérôme Fayette, Robert Haddad

|May 05, 2025
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC.

Christophe Le Tourneau, Zoltán Takácsi-Nagy, Sandra Nuyts

|Apr 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|Aug 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.

Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis

|Apr 14, 2023
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.

Niki Gavrielatou, Ioannis Vathiotis, Thazin Nwe Aung

Pageof 2

Frequent Collaborators

5 joint publications

Kevin J Harrington

5 joint publications

Makoto Tahara

4 joint publications

Barbara Burtness

3 joint publications

Robert Haddad